饮酒与代谢综合征:对肝病的临床与流行病学影响
饮酒与代谢综合征在人群中高度流行且常共存,均与慢性肝病、肝细胞癌及肝相关结局(如失代偿或肝移植)相关。关于轻中度饮酒对代谢综合征和脂肪肝风险的影响,研究结果不一,可能源于方法学差异。现有少量前瞻性研究提示轻中度饮酒与肝相关结局增加相关,系统生物学分析支持酒精与代谢综合征在脂肪肝病中可能作用相似。酒精与代谢因素独立且联合地与肝相关结局相关,代谢综合征增加肝相关结局风险且不受酒精摄入影响,其组分对肝相关结局风险似有累加效应,中心性/腹部肥胖指标(如腰臀比)可能比BMI更准确预测肝相关结局。
要点
- 轻中度饮酒与肝相关结局增加相关,系统生物学分析提示酒精与代谢综合征可能作用相似。
- 代谢综合征增加肝相关结局风险,不受酒精摄入影响,其组分对风险似有累加效应。
- 腰臀比等中心性肥胖指标可能比BMI更准确预测肝相关结局。
核心结论
- 酒精与代谢因素独立且联合地与肝相关结局相关,代谢综合征增加肝相关结局风险且不受酒精摄入影响。
- 轻中度饮酒与肝相关结局增加相关,系统生物学分析提示酒精与代谢综合征在脂肪肝病中可能作用相似。
- 代谢综合征组分对肝相关结局风险似有累加效应,许多研究甚至提示有害饮酒与多种代谢组分之间存在协同交互作用。
- 现有证据提示更整体的方法可能有助于风险预测、诊断和治疗规划。
研究设计与样本
- 本文为综述,汇总饮酒与代谢综合征对肝病临床与流行病学影响的相关研究。
主要发现
- 关于轻中度饮酒对代谢综合征和脂肪肝风险的影响,研究结果不一,可能源于方法学差异。
- 少量前瞻性研究提示轻中度饮酒与肝相关结局增加相关。
- 代谢综合征增加肝相关结局风险,不受酒精摄入影响。
- 代谢综合征组分对肝相关结局风险似有累加效应。
- 腰臀比等中心性/腹部肥胖指标可能比BMI更准确预测肝相关结局,包括有害饮酒者。
临床怎么用
- 现有证据提示更整体的方法可能有助于风险预测、诊断和治疗规划。
局限性
- 关于轻中度饮酒对代谢综合征和脂肪肝风险影响的研究结果不一,可能源于方法学差异。
- 仅有少量前瞻性研究可用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alcohol use and metabolic syndrome are highly prevalent in the population and frequently co-exist. Both are implicated in a large range of health problems, including chronic liver disease, hepatocellular carcinoma, and liver-related outcomes (i.e. decompensation or liver transplantation). Studies have yielded mixed results regarding the effects of mild-moderate alcohol consumption on the risk of metabolic syndrome and fatty liver disease, possibly due to methodological differences. The few available prospective studies have indicated that mild-moderate alcohol use is associated with an increase in liver-related outcomes. This conclusion was substantiated by systems biology analyses suggesting that alcohol and metabolic syndrome may play a similar role in fatty liver disease, potentiating an already existing dysregulation of common vital homeostatic pathways. Alcohol and metabolic factors are independently and jointly associated with liver-related outcomes. Indeed, metabolic syndrome increases the risk of liver-related outcomes, regardless of alcohol intake. Moreover, the components of metabolic syndrome appear to have additive effects when it comes to the risk of liver-related outcomes. A number of population studies have implied that measures of central/abdominal obesity, such as the waist-to-hip ratio, can predict liver-related outcomes more accurately than BMI, including in individuals who consume harmful quantities of alcohol. Many studies even point to synergistic interactions between harmful alcohol use and many metabolic components. This accumulating evidence showing independent, combined, and modifying effects of alcohol and metabolic factors on the onset and progression of chronic liver disease highlights the multifactorial background of liver disease in the population. The available evidence suggests that more holistic approaches could be useful for risk prediction, diagnostics and treatment planning.
引用
- Åberg F, Byrne CD, Pirola CJ, et al. Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease. J Hepatol. 2022. PMID: 36063967. doi:10.1016/j.jhep.2022.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。